Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | CSF1R | P07333 | 1/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | LTK | P29376 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.40 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.40 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.40 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.40 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30181056 | 1.00 | ALDH1A1 (0.62) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL17709513 | 1.00 | ALDH1A1 (0.62) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL17709511 | 1.00 | ALDH1A1 (0.62) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL28409534 | 0.96 | ALDH1A1 (0.58) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL17709517 | 0.94 | ALDH1A1 (0.56) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL169282 | 0.91 | ALDH1A1 (0.68) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL29564016 | 0.91 | ALDH1A1 (0.68) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL17709515 | 0.89 | ALDH1A1 (0.67) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL17709523 | 0.89 | ALDH1A1 (0.60) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R | |
| SCHEMBL10909218 | 0.88 | ALDH1A1 (0.65) | ALDH1A1HSD17B10L3MBTL1MAP4K4CSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115135316-A | Lipoxygenase inhibitors | 思研（SRI）国际顾问与咨询公司 | 2022-09-30 | — | — | CN | disclosed |
| US-10400163-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-03 | — | — | US | disclosed |
| EP-2362889-B1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP (US) | 2018-12-26 | — | — | EP | disclosed |
| CN-102361857-B | Can be used as the ring-type benzimidizole derivatives of antidiabetic | MERCK SHARP & DOHME CORP. (US) | 2015-09-16 | — | — | CN | disclosed |
| US-20140225069-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2014-08-14 | — | — | US | disclosed |
| CN-102272261-B | Phosphorescent emitters | UNIVERSAL DISPLAY CORP | 2014-02-26 | — | — | CN | disclosed |
| US-20130341599-A1 | Phosphorescent Emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2013-12-26 | — | — | US | disclosed |
| CN-103396455-A | Phosphorescent emitter | UNIVERSAL DISPLAY CORP | 2013-11-20 | — | — | CN | disclosed |
| US-8367223-B2 | Heteroleptic phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2013-02-05 | — | — | US | disclosed |
| CN-102271511-A | Novel cyclic benzimidazole derivatives useful anti-diabetic agents | — | 2011-12-07 | — | — | CN | disclosed |
| CN-102272261-A | Phosphorescent emitters | — | 2011-12-07 | — | — | CN | disclosed |
| CN-102264228-A | Novel cyclic benzimidazole derivatives for antidiabetic agents | — | 2011-11-30 | — | — | CN | disclosed |
| US-20100141127-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100141127-A1 | PHOSPHORESCENT EMITTERS | PAICS, TYMP, NUDT1 | ALDH1A1 695/4885HSD17B10 4746/4885L3MBTL1 930/4885 |
| US-10400163-B2 | Organic electroluminescent materials and devices | INTS9, SRSF9, PRMT9 | ALDH1A1 2082/4885HSD17B10 3847/4885L3MBTL1 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.